Novel oral RA treatment Xeljanz launched in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: Pfizer Japan and Takeda Pharmaceutical have launched Xeljanz (tofacitinib citrate) in Japan. The medicine was...Read more

Japan firms keen to collaborate with Indian pharma

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

Singapore: Japanese companies are keen to collaborate with pharmaceutical companies in India. A delegation of pharmaceut...Read more

Astellas to pay $300 mn for cancer drug conjugates

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...Read more

Eisai dissolves Palma Bee'Z Research Institute

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

Singapore: Japan-headquartered Eisai and its diagnostics business subsidiary Eidia have decided to dissolve and absorb t...Read more

Shimadzu extends ultra fast mass spectrometry range

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

Singapore: Shimadzu UK has launched a high-end liquid chromatography mass spectrometer, the LCMS-8080, which delivers be...Read more

Takeda seeks bowel drug marketing nod from EU

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

Singapore: Takeda Pharmaceutical submitted a marketing authorization application (MAA) to the European Medicines Agency ...Read more

Japan approves Accent MRI Pacemaker

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

Singapore: St Jude Medical, a global medical device company, has received approval from the Japanese Ministry of Health,...Read more

Japan, Korea lead in stem cell race

Japan |  Opinion | By Nandita Singh | 0 Comment | 12 Nov, 2012

In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...Read more

Exlites eyes more medtech deals from China, Taiwan, Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge m...Read more

NZ value-added dairy product launches in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

Singapore: New Zealand-based dairy biotechnology company, Quantec, announced that it has signed a distribution and suppl...Read more

Otsuka schizophrenia relapse gets FDA nod

Japan |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 01 Mar, 2013

Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...Read more

US FDA issues API bulk & tapped density guidance

Japan |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 11 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...Read more

Dezima in-licenses CETP inhibitor from Mitsubishi

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jan, 2013

Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licen...Read more

South Korea approves Halaven for breast cancer

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to...Read more

Takeda's foreign recruitments suffer hostility

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jun, 2014

Singapore: The former executives and shareholders of Takeda, a leading Japanese firm, have expressed their resentment ov...Read more

Orexo re-submits NDA for cancer pain killer in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Swedish specialty pharmaceutical company, Orexo, revealed that that its partner Kyowa Hakko Kirin submitted ...Read more

Eisai reveals phase III results of breast cancer drug Halaven

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2012

Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...Read more

Daiichi faces $100 mn law suit for gender discrimination

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Feb, 2013

Singapore: Six current and former female pharmaceutical sales professionals working with Daiichi Sankyo, US, have filed ...Read more